Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Paragonix Technologies

Explore full profile

Medical device company specialized in organ preservation devices for the improvement of donor organ quality

Cambridge, United StatesFounded 2010Biotech & Life Sciences
Valuation $100–250M Last recorded · 2023
Revenue $10–50M Latest reported FY
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Paragonix Technologies and the history behind them.

About Paragonix Technologies

Paragonix Technologies is a pioneering company in the medical device industry, specializing in advanced organ transport systems. The company serves healthcare providers, including hospitals and transplant centers, by offering state-of-the-art solutions for the safe and effective transportation of donor organs. Operating in the global healthcare market, Paragonix Technologies focuses on improving patient outcomes through its flagship products like the Paragonix Cardiac Transport System, Kidney Transport System, and Pancreas Transport System. These devices provide sterile, temperature, and pressure-controlled environments, ensuring the organs remain viable during transit.

The business model of Paragonix Technologies revolves around the sale of these specialized transport systems to healthcare institutions. Revenue is generated through direct sales, as well as through long-term contracts and service agreements with medical facilities. The company also collects and evaluates clinical effectiveness data through its GUARDIAN registry, which helps in continuously improving its products and services.

Source: Dealroom company data

At a glance

Founded
2010
Headquarters
Cambridge, United States
Sector
Biotech & Life Sciences
Power Law
Colt$25–100M revenue

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • US Department of Health and Human Services

Series A1 investor entered at this stage

  • Signet Healthcare Partners

Series B and later1 investor entered at this stage

  • Massachusetts Life Sciences Center
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States97.9%
🇦🇹 Austria0.7%
🇪🇸 Spain0.7%
3 countries shown
Web traffic by country
7.4K monthly visits
across markets
🇺🇸 United States73%
🇨🇦 Canada9.5%
🇮🇳 India9.5%
🇬🇧 United Kingdom8.1%
Top 4 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Paragonix Technologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Paragonix Technologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.